Delivery Order SPE2DB24D1034-SPE2DB25FWBG9

Award Date 3/20/25
Potential Completion Date 3/21/25
Potential Value $3.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $15,207.41 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 0.5mL VAXELIS vaccine syringes, with a performance period through November 5, 2024. This Delivery Order is placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. The IDC...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VAXELIS vaccine syringes. The $3,015.25 firm fixed-price contract has an ultimate completion date of October 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty...
The U.S. Defense Logistics Agency (DLA) awarded a $6,106.57 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide VAXELIS vaccine syringes. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a comprehensive vehicle for supplying a wide range of pharmaceutical products and medical supplies to support military healthcare...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,278.96 firm fixed-price delivery order is for the VAXELIS vaccine syringe 0.5ML, with a completion date of February 11, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This $3,586.26 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the VAXELIS Vaccine in 0.5mL vials, with a completion date of May 14, 2024. This contract award is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,557.92 firm fixed-price contract is for the delivery of the VAXELIS vaccine syringe 0.5 ML. The award has an ultimate completion date of February 4, 2025. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $1,239.24 firm fixed price delivery order contract to provide 0.5 mL VAXELIS vaccine syringes. The contract has a performance period through February 28, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor for this award, which does not have a set-aside designation. This delivery order is part of a larger indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,278.96 Firm Fixed Price Delivery Order is for the supply of VAXELIS vaccine syringes, 0.5mL, with a completion date of November 19, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,743.09, is for the delivery of VAXELIS vaccine syringes (0.5 mL) to support military healthcare programs. The contract is a firm fixed-price arrangement with a completion date of January 31, 2025. AmerisourceBergen holds a broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,278.96, is for the delivery of VAXELIS vaccine syringes (0.5 mL) and has a completion date of February 12, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. In addition to this delivery order, AmerisourceBergen holds...
  • SPE2DB24D1034
    Indefinite Delivery Contract
  • SPE2DB24D1034-SPE2DB25FWBG9
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $3,197.40 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VAXELIS vaccine syringes. The contract has an ultimate completion date of March 21, 2025 and is not designated as a set-aside requirement. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 6/21/25, 9:46 AM